Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSB2300116	重组人源化抗IL-17A单克隆抗体注射液	recombinant humanized anti-IL17A monoclonal antibody	Injection	Biological Products(1)	Supplementary Application	2023-10-21		Shanghai Jun Shi Biological Engineering Technology Co Ltd;Shanghai Junshi Biosciences Co Ltd			view
CXSB2300067	重组人源化抗IL-17A单克隆抗体注射液	recombinant humanized anti-IL17A monoclonal antibody	Injection	Biological Products(1)	Supplementary Application	2023-06-21		Shanghai Jun Shi Biological Engineering Technology Co Ltd;Shanghai Junshi Biosciences Co Ltd			view
CXSL2100009	重组人源化抗IL-17A单克隆抗体注射液	recombinant humanized anti-IL17A monoclonal antibody	Injection	Biological Products(1)	New Drug Application	2021-01-09	上海君实生物医药科技股份有限公司	Shanghai Junshi Biosciences Co Ltd	In Review	2021-01-08	view
CXSL1900061	重组人源化抗IL-17A单克隆抗体注射液	recombinant humanized anti-IL17A monoclonal antibody	Injection	Biological Products(1)	New Drug Application	2019-06-27	上海君实生物医药科技股份有限公司	Shanghai Junshi Biosciences Co Ltd;Shanghai Jun Shi Biological Engineering Technology Co Ltd;Suzhou Junmeng Biopharm Co Ltd;Suzhou UNION Biopharm Biosciences Co Ltd	In Review	2019-06-26	view